Isospec Analytics specializes in advanced biomolecular analysis, leveraging innovative technologies to enhance molecular identification and characterization. Their proprietary AI-enhanced infrared (IR) fingerprinting technology allows for rapid identification of new molecules, significantly reducing the time required for analysis from weeks to mere minutes. This technology is particularly valuable in the fields of biotechnology and drug development, where understanding the intricate details of molecular structures can lead to breakthroughs in disease detection and treatment. Additionally, Isospec's integration of cryogenic IR spectroscopy with ion mobility spectrometry (IMS-MS) aims to improve the identification of complex molecules, thereby minimizing analytical uncertainties and enhancing the reliability of results.

The company also focuses on glycan analysis, which is crucial for various applications, including infant nutrition and drug development. Their services include the characterization of human milk oligosaccharides and the identification of glycan fermentation products, utilizing a comprehensive database of glycan structures. By combining established analytical techniques such as liquid chromatography-mass spectrometry (LC-MS) with their proprietary technologies, Isospec Analytics provides actionable insights that facilitate biomarker discovery and therapeutic characterization. This multifaceted approach not only accelerates research but also empowers scientists to make informed decisions in their product development processes.

Switzerland

Isospec Analytics is a life science company that aims at simplifying molecular identification. They provide high detection sensitivity suitable for bioanalytical applications and offer next-level molecular intelligence to empower biotechnology. Their technology takes the guesswork out of biomolecular analysis and they have raised $1.9m for their breakthrough biomolecular analysis technology.

Isospec Analytics

Company Details